Provided by Tiger Trade Technology Pte. Ltd.

Verve Therapeutics

11.13
0.0000
Volume:- -
Turnover:114.94M
Market Cap:994.14M
PE:-5.30
High:11.13
Open:11.13
Low:11.13
Close:11.13
52wk High:11.41
52wk Low:2.86
Shares:89.32M
Float Shares:65.50M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1013
EPS(LYR):-2.3454
ROE:-34.26%
ROA:-19.35%
PB:2.10
PE(LYR):-4.75

Loading ...

Eli Lilly Reports Q2 2025 Revenue Surge of 38% to $15.56 Billion, EPS Up 92% to $6.29

Reuters
·
Aug 07, 2025

Verve Therapeutics Inc. Announces Delisting from Nasdaq Following Merger Completion

Reuters
·
Jul 26, 2025

Eli Lilly Completes Acquisition of Verve Therapeutics

MT Newswires Live
·
Jul 25, 2025

Eli Lilly Completes Tender Offer for Verve Therapeutics Shares

MT Newswires Live
·
Jul 24, 2025

Lilly and Verve Announce Expiration of Verve Tender Offer

THOMSON REUTERS
·
Jul 24, 2025

Verve Therapeutics Inc. Announces Retention Bonus Plan for Key Executives Amid Pending Acquisition

Reuters
·
Jul 15, 2025

Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs. -- Heard on the Street -- WSJ

Dow Jones
·
Jul 13, 2025

Verve Therapeutics Cut to Market Perform From Outperform by BMO Capital

Dow Jones
·
Jun 28, 2025

BMO Capital Downgrades Verve Therapeutics to Market Perform, $13.50 Price Target

MT Newswires Live
·
Jun 27, 2025

HC Wainwright Downgrades Verve Therapeutics to Neutral From Buy, $25 Price Target

MT Newswires Live
·
Jun 18, 2025

Sector Update: Health Care Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire

Reuters
·
Jun 18, 2025

Verve Therapeutics Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
Jun 17, 2025

Verve Therapeutics Up Over 74%, on Track for Record Percent Increase -- Data Talk

Dow Jones
·
Jun 17, 2025

Stock Track | Verve Therapeutics Soars 74% on Eli Lilly's $1.3 Billion Acquisition Deal

Stock Track
·
Jun 17, 2025

Deals of the day-Mergers and acquisitions

Reuters
·
Jun 17, 2025

US STOCKS-Wall Street set to open lower as Middle East conflict continues

Reuters
·
Jun 17, 2025

Lilly to Buy Gene-Editing Partner Verve for up to $1.3 Billion in Cardiac Care Push

Reuters
·
Jun 17, 2025

Pre-Bell|U.S. Futures Dip; Verve Surges 75%; Regencell Bioscience Jumps Another 30%; Solar Stocks Plunge

Tiger Newspress
·
Jun 17, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companies

Reuters
·
Jun 17, 2025